Skip to content

Effectiveness of Technology-based Interventions for the Improvement of Cognitive Processes in ADHD.

Effectiveness of Technology-based Interventions for the Improvement of Cognitive Processes in Children and Adolescents With ADHD.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06477575
Enrollment
40
Registered
2024-06-27
Start date
2024-03-01
Completion date
2024-06-21
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD, Deficits in Motor Control and Perception

Keywords

ADHD, cognitive rehabilitation, new technologies

Brief summary

To scientifically demonstrate the improvements in cognitive functions and core symptoms of children and adolescents diagnosed with ADHD through the implementation of a cognitive rehabilitation program based on the use of the most relevant technologies found in the systematic review carried out during the first phase. Two intervention groups will be randomly assigned for the study: G1: composed of 20 patients who will receive neurocognitive therapy based on new technologies. This will be the experimental group. G2: composed of 20 patients who will receive conventional neurocognitive therapy for ADHD treatment. This group will be the control group

Interventions

DEVICEneurocognitive therapy based on new technologies

The cognitive neurorehabilitation program is based on gaming through the use of the Nintendo Switch device. The following games have been chosen: Pufferfish, Hex Egg, Mystic Totem, Thor's Thunder, since they are games that work on selective attention, concentration and processing speed, which are the variables to be studied in this project. Hardware: Nintendo Switch Software: 60 in 1 game Games: Pufferfish, Hex Egg, Mystic Totem, Thor's Thunder. Therapy time: 30 minutes effective. Number of Sessions: 2 per week / Number of weeks: 8 Total number of intervention sessions: 16 sessions Place: Thercli Center (Don Benito).

OTHERconventional neurocognitive therapy

The cognitive neurorehabilitation program for group active comparator is based on playing more conventional board games that work on selective attention, concentration and processing speed, which are the variables to be studied in this project. Traditional games and token book. Games: Dobble, Lynx, Crazy cups, Jungle speed, animalea, ghost. Card: Stimulate and learn level 3 and 4. Therapy time: 30 minutes effective. No. of sessions: 2 per week / No. of weeks: 8 Total number of intervention sessions: 16 sessions Place: Thercli Center (Don Benito).

Sponsors

University of Extremadura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children and adolescents diagnosed with ADHD * Age: 6-17 years old

Exclusion criteria

* Children and adolescents diagnosed with ADHD + ADD. * Age: under 6 years old or over 17 years old. * Other psychopharmacological treatments not specific for ADHD.

Design outcomes

Primary

MeasureTime frameDescription
WisC-V (Wechsler intelligence scale for children)8 weeksprovides primary intelligence index scores that reflect intellectual functioning in different cognitive areas: verbal comprehension, visuospatial, fluid reasoning, working memory and processing speed.
STROOP (Colors and Words Test)8 weeksreference test for the detection of neuropsychological problems and brain damage. It allows to evaluate the phenomenon of interference, intimately linked to inhibitory control processes.
CARAS-R(Difference perception test)8 weeksevaluates the ability to quickly and correctly perceive similarities and differences in partially ordered patterns of stimulation. It measures perceptual and attentional skills by means of 60 graphic items consisting of schematic drawings of faces with elementary strokes.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026